ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 140 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $49,107 | -49.3% | 9,248 | -9.1% | 0.03% | -47.4% |
Q2 2023 | $96,939 | +44.8% | 10,172 | +67.1% | 0.06% | +54.1% |
Q1 2023 | $66,968 | -46.3% | 6,088 | -27.7% | 0.04% | -43.1% |
Q4 2022 | $124,660 | +23.4% | 8,423 | +59.7% | 0.06% | +62.5% |
Q3 2022 | $101,000 | -9.0% | 5,275 | +0.8% | 0.04% | -2.4% |
Q2 2022 | $111,000 | -44.5% | 5,232 | -49.5% | 0.04% | -54.4% |
Q1 2022 | $200,000 | -11.9% | 10,359 | -5.5% | 0.09% | +4.7% |
Q4 2021 | $227,000 | +30.5% | 10,965 | +50.1% | 0.09% | +11.7% |
Q3 2021 | $174,000 | -17.1% | 7,304 | -5.0% | 0.08% | -10.5% |
Q2 2021 | $210,000 | -29.5% | 7,692 | -25.3% | 0.09% | -31.7% |
Q1 2021 | $298,000 | +4.6% | 10,302 | +1.8% | 0.13% | +6.8% |
Q4 2020 | $285,000 | -19.5% | 10,117 | -16.3% | 0.12% | -36.6% |
Q3 2020 | $354,000 | -14.7% | 12,081 | -11.9% | 0.19% | -5.6% |
Q2 2020 | $415,000 | – | 13,718 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|